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We read with great interest the paper by Ahumada
et al. [1] on the association between asthma symptoms
and IgE responses to Ascaris and mites in a population
living in the tropics. They report for the first time in a
nationwide case–control study performed in Columbia
that IgE sensitization to house dust mite or Ascaris tro-
pomyosin has clinical relevance. They also report that
specific IgE to tropomyosins from Ascaris and mites
strongly correlate and speculate that co-exposure to
both mite and Ascaris generates conditions to increase
the allergic symptoms.
Anti-Ascaris IgE has been reported to increase the
risk of wheezing in low endemic areas, and we demon-
strated previously that elevated anti-Ascaris IgE was
associated with wheezing in children in rural Bangla-
desh, where as many as 75% of children were infected
with Ascaris [2]. A study performed later in the same
area of Bangladesh in 2008, when the infection preva-
lence was 17.4%, reported that anti-Ascaris IgE was
associated with increased risk of ever asthma in 5-year-
old children as well [3]. These findings suggest that
anti-Ascaris IgE is associated with increased risk of
wheezing regardless of exposure levels to Ascaris.
The prevalence of asthma in Bangladesh has been
increasing over the years. A nationwide cross-sectional
survey in 1999 reported 7.3% of asthma prevalence in
the children aged 5–14 years [4]. A subsequent study con-
ducted in 2000 among the schoolchildren aged 6–7 years
documented 9.1% of current wheezing [5]. Our later
research reported a further increase to a 16% prevalence
of current wheezing in 2001 among children aged 5–
6 years in a rural area [2], while a 2008 study described a
19.7% prevalence of current wheezing in the same area
among 5-year-old children [3]. This sudden increase of
the prevalence from 2000 to 2001 and the subsequent
slow increase between 2001 and 2008 also attracts our
attention. The annual increase in the prevalence of
asthma was reported 0.02% for the Indian subcontinent,
which includes Bangladesh [6].
On the other hand, the percentage change of Ascaris
infection in age-standardized prevalence from 1999 to
2013 was -44.8%, and the percentage change in age-
standardized years lived with disability (YDLs) from
1999 to 2013 was -80.1%. This percentage decrease in
age-standardized YDLs was the highest among all the
listed 301 acute and chronic diseases and injuries in
188 countries between 1990 and 2013 [7]. The infection
prevalence in Bangladesh also declined drastically after
introduction of the national programme of anti-hel-
minthic drug administration for children 24–59 months,
initiated in 2004, and an additional programme for
primary school-aged children [2,3]. The high prevalence
of the infection in 2001 and the subsequent sharp
decline until 2008 arrests our attention.
WHO has been implementing a programme since
2001 for people at risk in endemic areas in order to
eliminate soil-transmitted helminthic infections to
reduce intensity of infection and to protect infected
individuals from morbidity related to the worms har-
boured [8]. Major soil-transmitted helminths are Ascaris
lumbricoides, Trichuris trichiura and Ancylostoma duo-
denale. The morbidity related to the worms harboured
listed includes abdominal pain, general malaise and
weakness, impaired cognitive and physical development
[8]. The people at risk are preschool children and
school-age children, women of child baring age and
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adults in certain occupations such as tea-pickers or
miners [8]. WHO targets to eliminate the morbidity due
to soil-transmitted helminthiases in children by treating
regularly 75% of the children in endemic areas by 2020
[8]. It is anticipated that helminthic infection will be
eradicated in the near future. Despite this advance, an
unacceptably large number of people suffering from the
infection still remain [8].
WHO estimated in 2013 that there were over 270 mil-
lion preschool children and 600 million school-age chil-
dren in need of treatment of the diseases [8]. The
organization recommends the target countries in the
tropics to treat the children once a year when the infec-
tion prevalence of soil-transmitted helminths in the com-
munity is between 20% and 50%, and twice a year when
the prevalence is over 50%. According to the Country X
indicators of soil-transmitted helminthiasis of WHO in
2013, national coverage of the preventive treatment of
soil-transmitted helminthiasis in Bangladesh was 100%
among preschool-aged children and 80% among school-
age children [9]. The programme coverage is expressed
by the fraction using the total number of the annual
treatment children receive in the community as the
numerator, and the population of the children in the tar-
get age group as the denominator. In other words, when
10 children receive treatment twice a year, the number of
children treated is counted as ‘20’. As the treatment of
deworming is conducted twice a year per child in Bangla-
desh, the actual annual number of the children who
received treatment should be half of WHO’s estimate.
Accordingly, the Bangladesh government is going to
reduce the number of annual treatment to one because
the national coverage of the children treated regularly is
approaching 75%.
Ahumada et al. [1] hypothesize that co-exposure to
both mite and Ascaris generates conditions to increase
the allergic symptoms. Hawlader et al. [3] found that
anti-Ascaris IgE was significantly associated with anti-
DP IgE in rural Bangladesh, in addition to the fact that
anti-Ascaris IgE is associated with ever asthma. We
again focus on the high prevalence of Ascaris infection
in 2001 and the subsequent sharp decline until 2008.
We also focus on the sudden increase in asthma preva-
lence in 2001 followed by the slow increase during
2001 and 2008. Wheezing illness in this area might be
part of the morbidity related to the worms harboured.
However, if it is part of the morbidity, there should
have been a decline in the prevalence of wheezing after
2001. Similarly, if Ascaris infection suppresses asthma,
there should have been a continuing increase in the
prevalence of asthma. These findings mentioned above,
together with the results of the studies including ours,
have led us to speculate that the subsequent increase in
the asthma prevalence after 2001 had been suppressed
by the national deworming programme. Bangladesh
might have been in the era of co-exposure to both mite
and Ascaris in 2001. Although the national coverage of
the children treated regularly is approaching 75%,
the programme is for severe infection and morbidity.
There still remain a large number of lightly infected
children without symptoms. It is, therefore, of extreme
importance to examine the impact of Ascaris infection
on the development of asthma, in addition to the
described morbidity, among the children at risk, test-
ing the immunological status in Bangladesh in its
rapid transition in the prevalence of both asthma and
Ascaris infection. We would hope to see children cope
well with wheezing illnesses in Bangladesh based on
the scientific findings, including the findings in the
present study.
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